• Home Blog Tag Head and neck squamous cell carcinoma

Head and Neck Squamous Cell Carcinoma

pharma-news-immutep-pfizer-novo-nordisk-arcutis

Jul 16, 2024

Immutep’ First-Line Treatment Positive Outcomes; Pfizer’s Once-Daily Oral GLP-1 Agonist Danuglipron; FDA Issues Complete Response Letter to Novo Nordisk; Arcutis’ ZORYVE® Cream 0.15% FDA Approval; NICE Recommends Ebglyss For Moderate To Severe Atopic Dermatitis

Head and Neck Cancers Market

Mar 19, 2021

Navigating Through the Treatment Market Landscape of Head and Neck Cancers

Delveinsight

Jan 12, 2016

Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper